{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:50:37Z","timestamp":1791237037302,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Allakos"},{"name":"Aralez"},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002066","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Menarini"},{"name":"Merckle Recordati"},{"name":"Moxie"},{"DOI":"10.13039\/100008792","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004634","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004634","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uriach"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaci.2018.08.050","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T12:22:14Z","timestamp":1539087734000},"page":"788-791.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Real-life treatment of cholinergic urticaria with omalizumab"],"prefix":"10.1016","volume":"143","author":[{"given":"Sabine","family":"Altrichter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mati","family":"Chuamanochan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Knoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Asady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatevik","family":"Ohanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.08.050_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2332\/allergolint.13-OA-0611","article-title":"Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria","volume":"63","author":"Hiragun","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2018.08.050_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000320233","article-title":"Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria","volume":"154","author":"Metz","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2018.08.050_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","article-title":"Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Metz","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.08.050_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.08.050_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0091-6749(79)90159-3","article-title":"Evaluation of a patient with cold and cholinergic urticaria","volume":"63","author":"Sigler","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.08.050_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/cea.13023","article-title":"Cholinergic urticaria patients of different age groups have distinct features","volume":"47","author":"Asady","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2018.08.050_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/bjd.14540","article-title":"Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients","volume":"175","author":"Ghazanfar","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.08.050_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2013.08.011","article-title":"Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis","volume":"73","author":"Metz","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2018.08.050_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10286-017-0418-6","article-title":"Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management","volume":"28","author":"Fukunaga","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jaci.2018.08.050_bibE1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdermsci.2014.04.007","article-title":"Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria","volume":"75","author":"Altrichter","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2018.08.050_bibE2","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jdv.12739","article-title":"An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria","volume":"29","author":"Magerl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2018.08.050_bibE3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/bjd.14540","article-title":"Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients","volume":"175","author":"Ghazanfar","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2018.08.050_bibE4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2500\/aap.2013.34.3694","article-title":"Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria","volume":"34","author":"Viswanathan","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2018.08.050_bibE5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/ced.13173","article-title":"Long-term management of chronic spontaneous urticaria with omalizumab","volume":"42","author":"Pinto Gouveia","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.08.050_bibE6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jaci.2017.08.007","article-title":"Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria","volume":"140","author":"Ertas","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.08.050_bibE7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2016.07.047","article-title":"Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria","volume":"139","author":"Gericke","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918314295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918314295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:19:30Z","timestamp":1758791970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918314295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0091674918314295"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.08.050","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734217068.793551864","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life treatment of cholinergic urticaria with omalizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}